Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ardana buys Zentaris assets

Reproductive medicine company Ardana Bioscience (Edinburgh, U.K.) paid EUR4.5 million ($4.4 million) for Europeptides

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE